Comparative In Vitro Activities of Ciprofloxacin, Gemifloxacin, Grepafloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, Trovafloxacin, and Other Antimicrobial Agents against Bloodstream Isolates of Gram-Positive Cocci Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

ABSTRACT The in vitro activity of gemifloxacin against 316 bloodstream isolates of staphylococci, pneumococci, and enterococci was compared with the activities of six fluoroquinolones and three other antimicrobial agents. Of the antimicrobial agents tested, gemifloxacin was the most potent against penicillin-intermediate and -resistant pneumococci, methicillin-susceptible and -resistant Staphylococcus epidermidis isolates, and coagulase-negative staphylococci.

authors

Hardy, Dwight
Amsterdam, Daniel
Mandell, Lionel
Rotstein, Coleman

status

published

publication date

March 2000

has subject area

0605 Microbiology (FoR)
1108 Medical Microbiology (FoR)
1115 Pharmacology and Pharmaceutical Sciences (FoR)
Anti-Bacterial Agents (MeSH)
Anti-Infective Agents (MeSH)
Aza Compounds (MeSH)
Bacteremia (MeSH)
Ciprofloxacin (MeSH)
Fluoroquinolones (MeSH)
Gemifloxacin (MeSH)
Gram-Positive Bacterial Infections (MeSH)
Gram-Positive Cocci (MeSH)
Humans (MeSH)
Microbial Sensitivity Tests (MeSH)
Microbiology (Science Metrix)
Moxifloxacin (MeSH)
Naphthyridines (MeSH)
Ofloxacin (MeSH)
Piperazines (MeSH)
Quinolines (MeSH)

published in

Antimicrobial Agents and Chemotherapy Journal